Monsanto’s latest herbicide-resistant GMO soybeans face regulatory delays at home, abroad

Screen Shot at PM
Image: United Soybean Board/Flickr

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Soybean growers looking to try out new weapons in their fight against weeds will have to wait a while longer.

. . . .

Monsanto’s Roundup Ready 2 Xtend soybeans, which are resistant to both glyphosate and dicamba, are still on a regulatory hold, at least a year after the company expected. While the beans have been approved for planting this year, the EPA has held back on allowing over-the-top application of dicamba on the plants, nullifying part of the benefit.

ADVERTISEMENT

In addition, the European Union has not approved import of the beans.

Related article:  UK extends license for glyphosate 5 years, will put in place post-Brexit review process

Other products are also on a waiting list in some form or other. They include Dow’s Enlist Duo soybeans, which are resistant to both glyphosate and 2,4-D.

While the chemistry has been approved in the United States, China has not granted import approval.

. . . .

ADVERTISEMENT
ADVERTISEMENT

Dow expects a full launch for 2017, though the company acknowledges there is no guarantee on whether the beans will be allowed into Europe. Meanwhile, they are being grown for seed this year . . .

Read full, original post: Some GMO trait launches face regulatory delays

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend